The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Microglial activation in the pathogenesis of Huntington's disease
Open accessAbstract
gene that encodes huntingtin protein. Although HD is characterized by a predominant loss of neurons in the striatum and cortex, previous studies point to a critical role of aberrant accumulation of mutant huntingtin in microglia that contributes to the progressive neurodegeneration in HD, through both cell-autonomous and non-cell-autonomous mechanisms. Microglia are resident immune cells in the central nervous system (CNS), which function to surveil the microenvironment at a quiescent state. In response to various pro-inflammatory stimuli, microglia become activated and undergo two separate phases (M1 and M2 phenotype), which release pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), anti-inflammatory cytokines, and growth factors (TGF-β, CD206, and Arg1), respectively. Immunoregulation by microglial activation could be either neurotoxic or neuroprotective. In this review, we summarized current understanding about microglial activation in the pathogenesis and progression of HD, with a primary focus of M1 and M2 phenotype of activated microglia and their corresponding signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“indicating that this model likely does not fully recapitulate the neuroinflammation observed in endstage human Huntington's disease”
From Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease (2020) · cites this paper as Yang et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971 · cited 1×
“However, a recent study revealed that neurotoxic reactive astrocytes could be induced by activated microglia and consequently resulted in a similar expression profile of pro-inflammatory cytokines, which led to a more rapid death of neurons and oligodendrocytes (Liddelow et al., 2017).”
BackgroundNF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Adams, J., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W. Y., Goldenthal, S. B., Biglan, K., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,190
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Takeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,528
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–151 of 151
Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
Lim, D., Matute, C., Cavaliere, F., & Verkhratsky, A. (2025) · Handbook of Clinical Neurology · doi:10.1016/b978-0-443-19102-2.00012-0 · Cited by 8
Targeting N-Terminal Huntingtin with a Dual-sgRNA Strategy by CRISPR/Cas9
Wu, J., Tang, Y., & Zhang, C. (2019) · BioMed Research International · doi:10.1155/2019/1039623 · Cited by 7
Glial Cells as Key Mediators in the Pathophysiology of Neurodegenerative Diseases
Bogus, K., Marchesi, N., Campagnoli, L. I. M., Pascale, A., & Pałasz, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020884 · Cited by 10
Peripheral and central elevation of IL-8 in patients with Huntington’s disease
Fung, J. N., Lee, J. D., Adam, R. J., O’Sullivan, J. D., & Woodruff, T. M. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.02.003 · Cited by 5
Iyer, K. A., Tenchov, R., Sasso, J. M., Ralhan, K., Jotshi, J., Polshakov, D. A., Maind, A., & Zhou, Q. A. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00722 · Cited by 6
Microbiota dysbiosis impact on the immune system dysregulation in Huntington’s disease (HD)
Acharjee, P., Prasad, S. K., Singh, V. V., Ray, M., & Acharjee, A. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.04.002 · Cited by 5
Wolters, E. C., Strekalova, T. V., de Munter, J., & Kramer, B. W. W. (2021) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.04 · Cited by 6
The Role of HMGB1 in Infection-Related Cognitive Deficits
Irzan, F. I., Retinasamy, T., Wen, W. R., Sheng, E. T. M., Shaikh, M. F., & Arulsamy, A. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25544 · Cited by 4
Paldino, E., Montalesi, E., Fiocchetti, M., Dioguardi, F., Venditti, I., Olivieri, E., Marino, M., & Fusco, F. R. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115639 · Cited by 4
The Role of TLR4 in Neural Stem Cells–Mediated Neurogenesis and Neuroinflammation
Filippis, L. D., & Peri, F. (2020) · Progress in inflammation research · doi:10.1007/978-3-030-56319-6_9 · Cited by 4
Chowdhury, R., Hendlinger, A., Rieß, O., & Schulze-Hentrich, J. M. (2025) · Epigenomics · doi:10.1080/17501911.2025.2518909 · Cited by 3
Bockholt, H. J., Clemsen, J. D., Baker, B. T., Calhoun, V. D., & Paulsen, J. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052384 · Cited by 3
Lu, Y.-S., Hung, W.-C., Hsieh, Y., Tsai, P.-Y., Tsai, T.-H., Fan, H.-H., Chang, Y., Cheng, H.-K., Huang, S.-Y., Lin, H.-C., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.06.021 · Cited by 3
Self-citationDrug repurposing for neurodegenerative diseases
Shukla, H., John, D., Banerjee, S., & Tiwari, A. K. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.035 · Cited by 3
The Huntington’s disease drug pipeline: a review of small molecules and their therapeutic targets
Khan, S., Bano, N., Uversky, V. N., Ahamad, S., & Bhat, S. A. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.08.006 · Cited by 3
Biphasic Role of Microglia in Healthy and Diseased Brain
Kumar, M., Arora, P., & Sandhir, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_18 · Cited by 2
Pharmacology of natural bioactive compounds used for management of Huntington diseases: An overview
Gadade, D. D., Sareen, R., Jain, N., Shah, K., Kumar, V., Modi, A., & Chauhan, N. S. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100091 · Cited by 2
Ameliorative potential of metformin in LPS and glutamate-induced neurotoxicity in N2a cell-line
Deepshikha, Shekhar, N., Tyagi, S., & Thakur, A. K. (2025) · Cytotechnology · doi:10.1007/s10616-025-00777-9 · Cited by 2
Neuroinflammation in Huntington’s Disease
Lee, J. D., Lo, M. W., Fung, J. N., & Woodruff, T. M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_9 · Cited by 2
Pelzel, R. J., Herbst, M., Rozema, N. B., Solem, M. A., & Gómez‐Pastor, R. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00859 · Cited by 1
Zhou, R., Lin, X., Lin, J., Liao, Z., Ni, H., Lin, X., He, Q., & Ning, W. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103110 · Cited by 1
Lao, Z.-K., & Xu, N. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00546-4 · Cited by 1
Li, S., Wang, X., Ma, X., Ding, R., Cai, B., Song, H., Chen, Y., Yao, D., Chen, Y., Zhang, X., et al. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10178-z · Cited by 1
Targeting the cGAS–STING pathway mitigates Huntington disease pathogenesis in a knock-in mouse model
Kesharwani, A., Dagar, S., Zuniga, I., Monet, M. C., Halade, G. V., Upadhyay, G., Ramírez-Jarquín, U. N., López-Huerta, V. G., Mirza, E., Quan, N., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535879123 · Cited by 1
Naha, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820595-2.00014-x · Cited by 1
Zamora, C. A., Muhleman, M., & Castillo, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_35 · Cited by 1
Gall-Duncan, T., Ko, S. Y., Quick, I. K., Khan, M., Feng, K., Kelley, C. P., Coleman, A., Touzé, A., Tang, S., Mehkary, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650652 · Cited by 1
Neurogenesis is Altered Between and Across Brain Regions After Neurodegeneration and Injury
Perez, A. (2019) · CUNY Academic Works (City University of New York)
WIRELESS INFRASTRUCTURE: THE ROAD MAP TO HIGH DATA RATES.
Nilsson, M., & Nilsson, L. J. (2000)
Illustrated etiopathogenesis of Huntington's disease
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00002-9
Maszczyk, M., Lechowska, S., & Wrześniok, D. M. (2022) · Farmacja Polska · doi:10.32383/farmpol/148154
Molecular imaging in Huntington's disease
de Natale, E. R., Wilson, H., Niccolini, F., & Politis, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821651-4.00014-2
Secondary microglia formation center in the human fetal brainPreprint
Song, C., Chen, X., Ji, R., Liu, Y., Zhang, L., Gao, L., He, Q., Ma, L., & Saiyin, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.29.582659
Karati, D., Mukherjee, S., & Batabyal, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00013-9
Neuroinflammation-microglia and neurodegeneration
Fathy, A. M., Mostafa, D. M., Sedeq, H. T., Hassan, H. A., Abdullah, H. W., Fawzy, M. M., Abdelgilil, M. E., Ebrahim, Y. A., & El-Sayed, W. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00005-1
Microglial Signaling in Health and Disease
Oppenheimer, M. R., Singh, S., Antoine, D., Truitt, B., & Roy, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_8
Protein Aggregation and Neuroinflammation in Huntington’s Disease
Tallapragada, S. D., Singhmura, S., Ganguly, A., Mazumder, K., & Dey, Y. N. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_11
Wu, L., Lu, D., Yao, J.-Z., Zuo, W., & Xu, J. (2025) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2025.2593706
Abcouwer, S. F., Shanmugam, S., Muthusamy, A., Lin, C.-M., Kong, D., Hager, H. M., Liu, X., & Antonetti, D. A. (2021) · Figshare · doi:10.6084/m9.figshare.16456332
Study of vesicular glycolysis in health and Huntington's Disease
Cluskey, M. M. (2021) · theses.fr (ABES) · doi:10.70675/eb022640z9c3cz4467z940dz6b27765c296b
Yildirim-Balatan, C. (2021) · theses.fr (ABES) · doi:10.70675/3372ff2ez69a6z4970z881bze4dfe0a15571
Islam, J., Elina, K. C., Chaudhary, P. K., Ali, M. A. F., Abbas, H., Hasan, M., Kim, A., & Park, Y. S. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107411
Identification of secondary microglial formation centers in the human fetal brain
Song, C., Chen, X., Ji, R., Liu, Y., Han, Y., Ye, F., Zhang, L., Li, L., Gao, L., He, Q., et al. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20251801
Ferguson, M. W., Scheepers, S., Palpagama, T. H., Singh‐Bains, M. K., Laighneach, A., Morris, D. W., TURNER, C., Tippett, L. J., Waldvogel, H. J., Faull, R. L. M., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01526-5
Xie, R., Yuan, L., Cai, J., Liu, B., Wu, J., Ren, Z., Qin, Y., Yu, N., Li, J. H., & Zhou, G. (2026) · Neuroscience Letters · doi:10.1016/j.neulet.2026.138680
Pérez-Villavicencio, J., Villa-Robledo, O., Megchun-Vázquez, X., Uriarte-Jiménez, F., Rubio‐Osornio, M., & Serrano‐García, N. (2026) · Neuroglia · doi:10.3390/neuroglia7030023
Padole, V. N., & Kulkarni, Y. A. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01948-z
Grétarsdóttir, H. M., Cunningham, J. L., Rasmusson, A. J., Burman, J., Kultima, K., Paucar, M., Svenningsson, P., Constantinescu, R., & Niemelä, V. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14112-5
Gene therapy in Huntington’s disease (HD)
Tirgar, F., Hosseini, M., Alijanpour, S., Aghanoori, M.-R., Alijanpour, S., & Mahdavinataj, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40467-2.00011-7
Carlson, J. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2739334
Metadata
- Authors
- Yang, H.-M., Yang, S., Huang, S.-S., Tang, B.-S., & Guo, J.-F.
- Affiliations
- Emory University (US)
- ORCID
- Yang, Su
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-06-19
- Volume
- 9
- Pages
- 193-193
- ISSN
- 1663-4365 (ISSN-L)
- PMC
- PMC5474461
- OpenAlex
- W2625794193
- Cited by
- 151
- References
- 118
- Citations by year
- 2026: 20 · 2025: 15 · 2024: 19 · 2023: 16 · 2022: 16 · 2021: 17 · 2020: 21 · 2019: 17 · 2018: 7 · 2017: 2
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Aging Neuroscience (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81430023, 2016CX025, 2016YFC1306000, 81371405, 81571248)
- Central South University (2016CX025)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Huntington's disease, microglial activation, mutant huntingtin, M1/M2 microglial polarization, neuroinflammation, inflammatory cytokines, anti-inflammatory cytokines, neurodegeneration, striatum, signaling pathways, neuroprotection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
